Name: Human Internal Mammary Artery (IMA) Transplantation and Stenting: A Human Model to Study the Development of In-Stent Restenosis (Video) | JoVE Journal
Uploaded: 2012-05-09T12:00:00.000+00:00
Duration: 5 min 37 s
Description: Explore a humanized rat model for studying intimal hyperplasia after stent deployment using human internal mammary artery transplantation. This translational approach enables assessment of human stent responses in human tissue.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

playerTrialDesktop

The authors thank Christiane Pahrmann for her contribution. Special thanks to Ethicon, Norderstedt, Hamburg (Germany) for providing the suture material.
Funding
Sonja Schrepfer has received a research grant from the Deutsche Forschungsgemeinschaft (DFG) (SCHR992/3 1 and SCHR992/4-1).] The work was supported by the ISHLT Shumway Career Development Grant 2010 and the Falk Research Funding (Stanford University).

1. Internal Mammary Artery (IMA) Preparation
<ol>
	<li>The arterial endothelium is denuded by the passage of a 2-french Fogarty arterial embolectomy catheter (Baxter Healthcare, Deerfield, IL, USA). The catheter is pulled through the whole vessel length twice to ensure endothelial damage.</li>
	<li>Use any human stent of 8mm length and 2.5 mm-3 mm in diameter (e.g. Translumina, Yukon stent). CAUTION: The diameter of the stent should not exceed the vessel diameter by more than 10% to avoid pre- and post-stent stenosis. CAUTION: Don't switch the length of the stent within the same study.</li>
	<li>Deploy the stent using the appropriate balloon pressure (which is noted on the stent package) to achieve the desired diameter.</li>
	<li>Store stented IMA in 4 °C RPMI + heparin (500 IE/10 ml) on ice until transplantation.</li>
</ol>
2. Animal Preparation
RNU Nude (Crl:NIH-Foxn1rnu) rats (300-350 g) are housed under conventional conditions in scantainer ventilated cabinets, fed standard rat chow and autoclaved water ad libidum.
<ol>
	<li>Anesthetize rat with isoflurane (2.5-3%) using an induction chamber.</li>
	<li>Shave the abdominal hair and place the rat on its back and place a facemask over its nose and mouth to keep up the anesthesia.</li>
	<li>Disinfect the abdominal area widely using Provo-Iodine, next use 80% ethanol - repeat this step twice. Check reflexes pinching the hind feet to be sure that the rat is sufficient anesthetized.</li>
	<li>Under microscopic view, perform an upper median laparotomy to expose the infrarenal abdominal aorta.</li>
	<li>Place the intestines in a saline moisturized glove. Fold the glove around the intestines to prevent loss of moisture.</li>
	<li>Dissect the aorta from the infrarenal region to the bifurcation, carefully not to cause damage on the branches of the vessels.</li>
	<li>Use micro clamps to stop the aortic blood flow. Place the proximal clamp first, followed by the distal clamp.</li>
	<li>Remove an app. 0.5-0.7 mm aortic segment and flush the remaining aorta with heparin (200 units).</li>
	<li>Take the stented IMA and shorten it to the adequate length and position it into the gap.</li>
	<li>Connect the IMA to the recipient aorta, by running sutures using 8-0 prolene suture (Ethicon, Norderstedt, Germany).</li>
	<li>Carefully open the first cranial clamp and then the caudal clamp.</li>
	<li>There should be a visible pulse in the transplanted IMA and at the distal end of the aorta.</li>
	<li>Place the intestines back into the abdomen.</li>
	<li>Flush the abdomen with pre-warmed sterile saline.</li>
	<li>Close the muscle layer of the abdominal wall using 6-0 prolene running sutures (Ethicon, Norderstedt, Germany).</li>
	<li>While the rat is still in anesthesia, inject 4-5 mg/kg Carprofen subcutaneously.</li>
	<li>Administer post-surgical analgesia as appropriate (e.g. Carprofen or Meloxicam) for 3 days post surgery.</li>
</ol>
3. Representative Results
For histology, the specimens were fixed in 4% formalin, dehydrated in a graded series of alcohol, and infiltrated in a mixture (MMA I) of 80% methylmethacrylate and 20% dibutylphthalate for 1 day, MMA I with 1% dry benzoyl peroxide for 1 day, and MMA I with 3% dry benzoyl peroxide (MMA III) for 1-2 days at 4 °C. Thereafter, the specimens were polymerized in fresh MMA III in glass vials in a water bath on a pre-polymerized base. Slow polymerization was achieved by keeping the vials at 26 °C overnight, increasing the temperature to 28 °C the next morning, and then increasing the temperature gradually by 0.5 °C over 12 h until polymerization occurred. The polymerized blocks were sectioned at 5 μm thickness using a MICROM HM 360 microtome equipped with a tungsten carbide knife.
To identify the origin of proliferating cells (Figure 1), slides were stained with antibodies identifying either the green fluorescent protein (GFP) or rat MHC-I and human smooth muscle cells. For these studies, human IMA was incubated with the reporter gene GFP overnight using lentiviral particles for stable transduction of IMA cells. Dividing daughter cells from human origin could be identified by expressing GFP. After deparaffinization, heat-induced epitope retrieval is performed by heating the slides in antigen retrieval solution using a steamer. The Image-iT FX signal enhancer can be used for the blocking step. Cells of human origin are identified using the mouse monoclonal antibodies against GFP (1:100 diluted in primary antibody diluent (Dako)), and further labeled with goat-anti-mouse IgG, Alexa Fluor 488 (1:1000 diluted in secondary antibody diluent). The smooth muscle cells were marked with the rabbit polycolonal anti-smooth muscle α-actin (1:100 diluted in primary antibody diluent), followed by goat-anti-rabbit IgG, Alexa Fluor 555 (1:1000 diluted in secondary antibody diluents). Each antibody incubation step is performed at 37 °C for 1 hour with three times PBS washing in between. Nuclei are stained with DAPI for 10 minutes. After mounting of the slides using Prolong Gold antifade reagent, samples were analyzed using confocal microscopy.
<img alt="Fluorescence microscopy, GFP/DAPI, SMA/DAPI, rat MHC-I, tissue staining, cell imaging comparison." src="/files/ftp_upload/3663/3663fig1.jpg" data-altupdatedat="1787630408000" data-alt="Figure 1"> 
Figure 1. The neointimal cells as human smooth muscle cells. A: Green= anti GFP, labeling cells of human origin; red=anti human smooth muscle cell actin; blue=DAPI, identifying cell nuclei. B: Green= anti rat MHC-I, labeling cells of rat origin; red=anti human smooth muscle cell actin; blue=DAPI, identifying cell nuclei. Proliferating cells are identified as smooth muscle cells and positive for GFP, but negative for the rat MHC-I molecule. Therefore, proliferating cells are human origin.

<ol><li>Deuse, T., Ikeno, F., Robbins, R. C., Schrepfer, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Imaging+In-Stent+Restenosis%3A+An+Inexpensive%2C+Reliable%2C+and+Rapid+Preclinical+Model%5BTitle%5D)+AND+%22J.+Vis.+Exp%22%5BJournal%5D)">Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model.</a> J. Vis. Exp. (31), e1346(2009).</li>
<li>Oyamada, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Trans-iliac+rat+aorta+stenting%3A+a+novel+high+throughput+preclinical+stent+model+for+restenosis+and+thrombosis%5BTitle%5D)+AND+%22J.+Surg.+Res%22%5BJournal%5D)">Trans-iliac rat aorta stenting: a novel high throughput preclinical stent model for restenosis and thrombosis.</a> J. Surg. Res. 166, e91-e95 (2011).</li>
<li>Chamberlain, J. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((A+novel+mouse+model+of+in+situ+stenting%5BTitle%5D)+AND+%22Cardiovascular+research%22%5BJournal%5D)">A novel mouse model of in situ stenting.</a> Cardiovascular research. 85, 38-44 (2010).</li>
<li>Deuse, T. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Introducing+the+first+polymer-free+leflunomide+eluting+stent%5BTitle%5D)+AND+%22Atherosclerosis%22%5BJournal%5D)">Introducing the first polymer-free leflunomide eluting stent.</a> Atherosclerosis. 200, 126-134 (2008).</li>
<li>Finn, A. V. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Differential+healing+after+sirolimus%2C+paclitaxel%2C+and+bare+metal+stent+placement+in+combination+with+peroxisome+proliferator-activator+receptor+gamma+agonists%3A+requirement+for+mTOR%2FAkt2+in+PPARgamma+activation%5BTitle%5D)+AND+%22Circulation+research%22%5BJournal%5D)">Differential healing after sirolimus, paclitaxel, and bare metal stent placement in combination with peroxisome proliferator-activator receptor gamma agonists: requirement for mTOR/Akt2 in PPARgamma activation.</a> Circulation research. 105, 1003-1012 (2009).</li>
<li>Tellez, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Coronary+bare+metal+stent+implantation+in+homozygous+LDL+receptor+deficient+swine+induces+a+neointimal+formation+pattern+similar+to+humans%5BTitle%5D)+AND+%22Atherosclerosis%22%5BJournal%5D)">Coronary bare metal stent implantation in homozygous LDL receptor deficient swine induces a neointimal formation pattern similar to humans.</a> Atherosclerosis. 213, 518-524 (2010).</li>
<li>Suzuki, Y., Yeung, A. C., Ikeno, F. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((The+pre-clinical+animal+model+in+the+translational+research+of+interventional+cardiology%5BTitle%5D)+AND+%22JACC+Cardiovasc.+Interv%22%5BJournal%5D)">The pre-clinical animal model in the translational research of interventional cardiology.</a> JACC Cardiovasc. Interv. 2, 373-383 (2009).</li>
<li>Holt, C. M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Intimal+proliferation+in+an+organ+culture+of+human+internal+mammary+artery%5BTitle%5D)+AND+%22Cardiovascular+research%22%5BJournal%5D)">Intimal proliferation in an organ culture of human internal mammary artery.</a> Cardiovascular research. 26, 1189-1194 (1992).</li>
<li>Swanson, N., Javed, Q., Hogrefe, K., Gershlick, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Human+internal+mammary+artery+organ+culture+model+of+coronary+stenting%3A+a+novel+investigation+of+smooth+muscle+cell+response+to+drug-eluting+stents%5BTitle%5D)+AND+%22Clin.+Sci.+%28Lond%29%22%5BJournal%5D)">Human internal mammary artery organ culture model of coronary stenting: a novel investigation of smooth muscle cell response to drug-eluting stents.</a> Clin. Sci. (Lond). 103, 347-353 (2002).</li>
</ol>

No conflicts of interest declared.

Although different in vivo research models are existing to investigate the development of intimal hyperplasia after stent placement, these models still facing translational hurdles to overcome. Furthermore, large animal models are expensive and special housing conditions as well as surgical equipment is not available for all laboratories.
Using a human IMA to study the development of human intimal proliferation and in-stent restenosis was studied before ex situ in organ ...

<table><tbody><tr><td>2 French Fogarty catheter</td><td>Baxter Internationl Inc.</td><td>120602F</td><td></td></tr><tr><td>Yukon Stent</td><td>Translumina GmbH, Hechingen, Germany</td><td></td><td>Use the stent of your choice according to your study protocol</td></tr><tr><td>RPMI media</td><td>Biochrom AG</td><td>Nr.F1275</td><td></td></tr><tr><td>heparin</td><td>Baxter Internationl Inc.</td><td>2B0953</td><td></td></tr><tr><td>isoflurane</td><td>Abbott Laboratories</td><td>B506</td><td></td></tr><tr><td>Provo-Iodine</td><td>Betadine Puredue Pharma</td><td>EAN:5995327165830</td><td></td></tr><tr><td>80% ethanol</td><td>Geyer</td><td>ETV 80/0500</td><td></td></tr><tr><td>Micro clamp</td><td>Harvard Apparatus</td><td>PY2-61-0186</td><td></td></tr><tr><td>Sutures 8-0</td><td>Johnson &amp;amp; Johnson</td><td>2808G</td><td></td></tr><tr><td>Sutures 6-0</td><td>Johnson &amp;amp; Johnson</td><td>1698 H</td><td></td></tr><tr><td>Carprofen</td><td>Feizer Vet</td><td>PZN:0110208</td><td></td></tr><tr><td>Metamizol</td><td>Ratiopharm</td><td></td><td></td></tr><tr><td>Target retrieval solution, pH9</td><td>Dako</td><td>S2368</td><td></td></tr><tr><td>Image-iT FX signal enhancer </td><td>Invitrogen</td><td>I36933</td><td></td></tr><tr><td>mouse monoclonal anti-GFP antibody </td><td>BD Biosciences</td><td>632381</td><td></td></tr><tr><td>primary antibody diluent </td><td>Dako</td><td>S3022</td><td></td></tr><tr><td>goat-anti-mouse IgG, Alexa Fluor 488 </td><td>Invitrogen</td><td>A11017</td><td></td></tr><tr><td>secondary antibody diluent </td><td>Dako</td><td>S0809</td><td></td></tr><tr><td>rabbit polycolonal anti-smooth muscle &amp;alpha;-actin </td><td>Abcam</td><td>ab5694</td><td></td></tr><tr><td>goat-anti-rabbit IgG, Alexa Fluor 555 </td><td>Invitrogen</td><td>A21430</td><td></td></tr><tr><td>Prolong Gold antifade reagent</td><td>Invitrogen</td><td>P36930</td><td></td></tr></tbody></table>

human internal mammary artery (ima) transplantation and stenting: a human model to study the development of in-stent restenosis

Human Internal Mammary Artery (IMA) Transplantation and Stenting: A Human Model to Study the Development of In-Stent Restenosis

Preclinical in vivo research models to investigate pathobiological and pathophysiological processes in the development of intimal hyperplasia after vessel stenting are crucial for translational approaches1,2.
The commonly used animal models include mice, rats, rabbits, and pigs3-5. However, the translation of these models into clinical settings remains difficult, since those biological processes are already studied in animal vessels but never performed before in human research models6,7. In this video we demonstrate a new humanized model to overcome this translational gap. The shown procedure is reproducible, easy, and fast to perform and is suitable to study the development of intimal hyperplasia and the applicability of diverse stents.
This video shows how to perform the stent technique in human vessels followed by transplantation into immunodeficient rats, and identifies the origin of proliferating cells as human.

This video shows a model to study the development of intimal hyperplasia after stent deployment using a human vessel (IMA) in an immunodeficient rat model.

Preclinical in vivo research models to investigate pathobiological and pathophysiological processes in the development of intimal hyperplasia after vessel ...

The overall goal of this procedure is to study the development of intimal hyperplasia in a humanized model. This is accomplished by first denuding, a section of human mammary artery or IMA, using a two French fogerty catheter. Next, a stent is inserted into the IMA.Then a segment of rat abdominal aorta is replaced with a stented IMA. Finally, the wound is sutured and the animal is allowed to recover the endothelial damage due to the invasive procedure of balloon dilatation and stenting results in inflammation and the production of inflammatory cytokines. This leads to the proliferation of smooth muscle cells, which progressively occlude the vessel lumen resulting in stenosis.Ultimately, results can be obtained that show the proliferation of human smooth muscle cells through immunofluorescence confocal microscopy. Today we will show you a model for the assessment of wrist stenosis in human arteries in a red host. The advantage of this model of existing techniques like the abdominal wet aortic standing, is that we can assess human stents in human tissue.We first had the idea for this method when we were aiming to find a translational in vivo model for vascular remodeling. To prepare

human-internal-mammary-artery-ima-transplantation-stenting-human

Research

JoVE Journal

Medicine

This video demonstrates how to use a preclinical inexpensive and reliable model to study pathobiological and pathophysiological processes of in-stent restenosis development. Longitudinal in vivo monitoring using OCT (Optical Coherence Tomography) and analysis of OCT images are also demonstrated.

Imaging In-Stent Restenosis: An Inexpensive, Reliable, and Rapid Preclinical Model

A model of stent implantation in mouse carotid artery is described. Compared to other similar methods, this procedure is very rapid, simple and accessible, offering the possibility to study in a convenient way the vascular wall reaction to different drug-eluting stents and the molecular mechanisms of restenosis.

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

We describe a surgical technique that produces wire injury in the femoral artery of mice to induce neointimal hyperplasia to serve as a model testing system for the perivascular delivery of therapeutic compounds for the inhibition of restenosis.

Murine Model of Femoral Artery Wire Injury with Implantation of a Perivascular Drug Delivery Patch

Restenosis following cardiovascular procedures (bypass surgery, angioplasty, or stenting) is a significant problem reducing the durability of these procedures. An ideal therapy would inhibit smooth muscle cell (VSMC) proliferation while promoting regeneration of the endothelium. We describe a model for simultaneous assessment of VSMC proliferation and endothelial function in vivo.

Murine Aortic Crush Injury: An Efficient In Vivo Model of Smooth Muscle Cell Proliferation and Endothelial Function

This work demonstrates a novel approach to assess the proliferation, differentiation, and vessel-forming potential of vascular endothelial stem cells (VESCs) through mammary fat pad transplantation followed by whole-mount tissue preparation for microscopic observation. A lineage tracing strategy to investigate the behavior of VESCs in vivo is also presented.

A Novel Mammary Fat Pad Transplantation Technique to Visualize the Vessel Generation of Vascular Endothelial Stem Cells

This article demonstrates a murine model to study the development of myointimal hyperplasia (MH) after aortic balloon injury.

Balloon-based Injury to Induce Myointimal Hyperplasia in the Mouse Abdominal Aorta

The present protocol aims to experimentally create venous intimal hyperplasia by subjecting veins to arterial blood pressure for developing strategies to attenuate venous intimal hyperplasia following revascularization surgery using vein grafts.

A Rabbit Venous Interposition Model Mimicking Revascularization Surgery using Vein Grafts to Assess Intimal Hyperplasia under Arterial Blood Pressure

This protocol describes the implantation of human coronary stents into the abdominal aorta of rats with an apoE-/- background using a trans-femoral access. Compared with other animal models, murine models carry the advantages of high throughput, reproducibility, ease of handling and housing, and a broad availability of molecular markers.

Implantation of Human-Sized Coronary Stents into Rat Abdominal Aorta Using a Trans-Femoral Access

Here we present a murine model for femoral artery anastomosis, offering researchers a valuable animal model to study and simulate vascular anastomotic stenosis. This development is crucial for advancing our understanding of the pathophysiology underlying this condition and facilitating more accurate and effective research into vascular diseases.

Development of a Murine Model for Femoral Artery Anastomotic Stenosis

This video demonstrates the orthotopic aortic transplant model as a simple model to study the development of transplant vasculopathy (TVP) in rats. <br...

Orthotopic Aortic Transplantation: A Rat Model to Study the Development of Chronic Vasculopathy

Explore a humanized rat model for studying intimal hyperplasia after stent deployment using human internal mammary artery transplantation. This translational approach enables assessment of human stent responses in human tissue.

Human Internal Mammary Artery (IMA) Transplantation and Stenting: A Human Model to Study the Development of In-Stent Restenosis

Explore More Videos